{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T09:21:27Z","timestamp":1785403287000,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T00:00:00Z","timestamp":1694390400000},"content-version":"vor","delay-in-days":3024,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jpain.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pain"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jpain.2015.03.004","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T04:45:12Z","timestamp":1430973912000},"page":"569-579.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["A Retrospective Cohort Study of Long-Term Immediate-Release Hydrocodone\/Acetaminophen Use and Acetaminophen Dosing Above the Food and Drug Administration Recommended Maximum Daily Limit Among Commercially Insured Individuals in the United States (2008\u20132013)"],"prefix":"10.1016","volume":"16","author":[{"given":"Angela","family":"DeVeaugh-Geiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditi","family":"Kadakia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Chilcoat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpain.2015.03.004_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1477-7517-6-8","article-title":"Can abuse deterrent formulations make a difference? Expectation and speculation","volume":"6","author":"Budman","year":"2009","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.jpain.2015.03.004_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1472-684X-9-14","article-title":"Dose patterns in commercially insured subjects chronically exposed to opioids: A large cohort study in the United States","volume":"9","author":"Cepeda","year":"2010","journal-title":"BMC Palliat Care"},{"key":"10.1016\/j.jpain.2015.03.004_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain","volume":"10","author":"Chou","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.jpain.2015.03.004_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1472-6904-12-11","article-title":"Population prevalence of high dose paracetamol in dispensed paracetamol\/opioid prescription combinations: An observational study","volume":"12","author":"Clark","year":"2012","journal-title":"BMC Clin Pharmacol"},{"key":"10.1016\/j.jpain.2015.03.004_bib5","unstructured":"Department of Health and Human Services, Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology. Drug utilization review for hydrocodone-containing combination products and comparators. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/AnestheticAndAnalgesicDrugProductsAdvisoryCommittee\/UCM330683.pdf. Accessed August 5, 2013"},{"key":"10.1016\/j.jpain.2015.03.004_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/AJP.0b013e3181b99f35","article-title":"Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: The TROUP study","volume":"26","author":"Edlund","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2015.03.004_bib7","unstructured":"Food and Drug Administration: Acetaminophen overdose and liver injury\u2014Background and options for reducing injury. Available at: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/DrugSafetyandRiskManagementAdvisoryCommittee\/UCM164897.pdf. Accessed August 12, 2013"},{"key":"10.1016\/j.jpain.2015.03.004_bib8","unstructured":"Food and Drug Administration: Labeling supplement and PMR requirement. Available at: http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/InformationbyDrugClass\/UCM367697.pdf. Accessed April 16, 2014"},{"key":"10.1016\/j.jpain.2015.03.004_bib9","unstructured":"Food and Drug Administration: Questions and answers about oral prescription acetaminophen products to be limited to 325 mg per dosage unit. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/InformationbyDrugClass\/ucm239871.htm. Accessed August 12, 2013"},{"key":"10.1016\/j.jpain.2015.03.004_bib10","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1002\/pds.3350","article-title":"Prevalence and correlates of exceeding the labeled maximum dose of acetaminophen among adults in a U.S.-based internet survey","volume":"21","author":"Kaufman","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpain.2015.03.004_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/jama.287.3.337","article-title":"Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey","volume":"287","author":"Kaufman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jpain.2015.03.004_bib12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.pain.2008.01.027","article-title":"Prevalence and characteristics of opioid use in the US adult population","volume":"138","author":"Kelly","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.jpain.2015.03.004_bib13","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1056\/NEJMra021844","article-title":"Drug-induced hepatotoxicity","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpain.2015.03.004_bib14","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1007\/s11606-011-1771-0","article-title":"Long- term chronic opioid therapy discontinuation rates from the TROUP study","volume":"26","author":"Martin","year":"2011","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jpain.2015.03.004_bib15","unstructured":"McPherson ML. Demystifying Opioid Conversion Calculations: A Guide for Effective Dosing. Bethesda, MD: American Society of Health-System Pharmacists, 2008. [2011 Update. http:\/\/www.ashp.org\/DocLibrary\/Bookstore\/P1985\/2011-Update.aspx. Accessed February 2015]"},{"key":"10.1016\/j.jpain.2015.03.004_bib16","unstructured":"Merck Manual: Acetaminophen poisoning. Available at: http:\/\/www.merckmanuals.com\/professional\/injuries_poisoning\/poisoning\/acetaminophen_poisoning.html?qt=acetaminophen&alt=sh. Accessed October 24, 2014"},{"key":"10.1016\/j.jpain.2015.03.004_bib17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2165\/11593100-000000000-00000","article-title":"Opioid-paracetamol prescription patterns and liver dysfunction. A retrospective cohort study in a population served by a US health benefits organization","volume":"34","author":"Mort","year":"2011","journal-title":"Drug Saf"},{"key":"10.1016\/j.jpain.2015.03.004_bib18","series-title":"MS Contin [package insert]","year":"2014"},{"key":"10.1016\/j.jpain.2015.03.004_bib19","series-title":"OxyContin [package insert]","year":"2014"},{"key":"10.1016\/j.jpain.2015.03.004_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/pds.755","article-title":"Prescription and non-prescription analgesic use among the US adult population: Results from the third National Health and Nutrition Examination Survey (NHANES III)","volume":"12","author":"Paulose-Ram","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpain.2015.03.004_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3122\/jabfm.2014.03.130290","article-title":"Risk of adverse health outcomes with increasing duration and regularity of opioid therapy","volume":"27","author":"Paulozzi","year":"2014","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/j.jpain.2015.03.004_bib22","series-title":"Roxicodone [package insert]","year":"2012"},{"key":"10.1016\/j.jpain.2015.03.004_bib23","first-page":"449","article-title":"Estimating medication persistency using administrative claims data","volume":"11","author":"Sikka","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jpain.2015.03.004_bib24","series-title":"Vicodin [package insert]","year":"2006"},{"key":"10.1016\/j.jpain.2015.03.004_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/AJP.0b013e318169d03b","article-title":"De facto long-term opioid therapy for noncancer pain","volume":"24","author":"Von Korff","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jpain.2015.03.004_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/1477-7517-7-24","article-title":"Route of administration for illicit prescription opioids: A comparison of rural and urban drug users","volume":"7","author":"Young","year":"2010","journal-title":"Harm Reduct J"}],"container-title":["The Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590015005970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526590015005970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T22:56:49Z","timestamp":1694905009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526590015005970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1526590015005970"],"URL":"https:\/\/doi.org\/10.1016\/j.jpain.2015.03.004","relation":{},"ISSN":["1526-5900"],"issn-type":[{"value":"1526-5900","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Retrospective Cohort Study of Long-Term Immediate-Release Hydrocodone\/Acetaminophen Use and Acetaminophen Dosing Above the Food and Drug Administration Recommended Maximum Daily Limit Among Commercially Insured Individuals in the United States (2008\u20132013)","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pain","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpain.2015.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}